Literature DB >> 21239204

Stereotactic radiation therapy and selective internal radiation therapy for hepatocellular carcinoma.

A Bujold1, L A Dawson.   

Abstract

Recent technological advances allow precise and safe radiation delivery in hepatocellular carcinoma. Stereotactic body radiotherapy is a conformal external beam radiation technique that uses a small number of relatively large fractions to deliver potent doses of radiation therapy to extracranial sites. It requires stringent breathing motion control and image guidance. Selective internal radiotherapy or radioembolization refers to the injection of radioisotopes, usually delivered to liver tumors via the hepatic artery. Clinical results for both treatments show that excellent local control is possible with acceptable toxicity. Most appropriate patient populations and when which type of radiation therapy should be best employed in the vast therapeutic armamentarium of hepatocellular carcinoma are still to be clarified.
Copyright © 2010 Société française de radiothérapie oncologique (SFRO). Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21239204     DOI: 10.1016/j.canrad.2010.11.003

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  18 in total

1.  Radiobiological effect induced by different activities of (125)I seed brachytherapy in a hepatocellular carcinoma model.

Authors:  Qing-Hong Qin; Bai-Sha Huang; Qi-Xing Tan; Wei-Ping Yang; Bin Lian; Chang-Yuan Wei
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 2.  Image-guided therapies in the treatment of hepatocellular carcinoma: A multidisciplinary perspective.

Authors:  Jonathon Willatt; Kevin K Hannawa; Julie A Ruma; Timothy L Frankel; Dawn Owen; Pranab M Barman
Journal:  World J Hepatol       Date:  2015-02-27

Review 3.  Yttrium-90 microspheres: a review of its emerging clinical indications.

Authors:  Natthida Khajornjiraphan; Nyein Aye Thu; Pierce Kah Hoe Chow
Journal:  Liver Cancer       Date:  2015-03       Impact factor: 11.740

Review 4.  Radiation therapy has been shown to be adaptable for various stages of hepatocellular carcinoma.

Authors:  Yasuteru Kondo; Osamu Kimura; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

5.  Radiotherapy with volumetric modulated arc therapy for hepatocellular carcinoma patients ineligible for surgery or ablative treatments.

Authors:  P-M Wang; W-C Hsu; N-N Chung; F-L Chang; A Fogliata; L Cozzi
Journal:  Strahlenther Onkol       Date:  2013-02-20       Impact factor: 3.621

6.  Stereotactic radiosurgery for brain metastases from hepatocellular carcinoma.

Authors:  Jung Ho Han; Dong Gyu Kim; Hyun-Tai Chung; Sun Ha Paek; Chul-Kee Park; Chae-Yong Kim; Young-Hoon Kim; Hee-Won Jung
Journal:  J Neurooncol       Date:  2013-06-29       Impact factor: 4.130

7.  Imaging Findings Within the First 12 Months of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy.

Authors:  Mishal Mendiratta-Lala; Everett Gu; Dawn Owen; Kyle C Cuneo; Latifa Bazzi; Theodore S Lawrence; Hero K Hussain; Matthew S Davenport
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-08-24       Impact factor: 7.038

8.  Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors.

Authors:  Ozlem N Kucuk; Cigdem Soydal; Seda Lacin; Elgin Ozkan; Sadik Bilgic
Journal:  World J Surg Oncol       Date:  2011-08-06       Impact factor: 2.754

9.  DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survival.

Authors:  Liam Cornell; Joanne M Munck; Clara Alsinet; Augusto Villanueva; Laura Ogle; Catherine E Willoughby; Despina Televantou; Huw D Thomas; Jennifer Jackson; Alastair D Burt; David Newell; John Rose; Derek M Manas; Geoffrey I Shapiro; Nicola J Curtin; Helen L Reeves
Journal:  Clin Cancer Res       Date:  2014-12-05       Impact factor: 12.531

10.  Radiation treatment with volumetric modulated arc therapy of hepatocellular carcinoma patients. Early clinical outcome and toxicity profile from a retrospective analysis of 138 patients.

Authors:  Po-Ming Wang; Wei-Chung Hsu; Na-Na Chung; Feng-Ling Chang; Antonella Fogliata; Luca Cozzi
Journal:  Radiat Oncol       Date:  2012-12-08       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.